TURQOZ Drug Patent Profile
✉ Email this page to a colleague
When do Turqoz patents expire, and what generic alternatives are available?
Turqoz is a drug marketed by Lupin Ltd and is included in one NDA.
The generic ingredient in TURQOZ is ethinyl estradiol; norgestrel. There are twenty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestrel profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TURQOZ?
- What are the global sales for TURQOZ?
- What is Average Wholesale Price for TURQOZ?
Summary for TURQOZ
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| DailyMed Link: | TURQOZ at DailyMed |
US Patents and Regulatory Information for TURQOZ
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Ltd | TURQOZ | ethinyl estradiol; norgestrel | TABLET;ORAL-28 | 202980-001 | Jul 31, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
